Mechanistically, low expression of FOXO3, which is associated with poor prognosis in ovarian cancer, suppresses GSK3β activity and upregulates PD-L1 expression, thereby inhibiting T-cell activity and ultimately facilitating immune evasion. This evidence concerns the gene CD274 and ovarian cancer.